IDH mutant gliomas can be subdivided into three groups according to the presence of the 1p16q codeletion and to the glioma CpG island methylator phenotype (G-CIMP)-high and -low methylation status [106]. The gene discussed is IDH2; the disease is central nervous system cancer.